Some people have reported they find standing or walking painful while on the medication and even that their shoe size has ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Injectible weight-loss drugs such as Ozempic can be life-changing for ... But as weight-loss drugs surge in popularity users have reported unexpected side effects, spanning gastrointestinal ...

U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...

It's been reported that bankruptcy is looming for WeightWatchers as the dieting firm struggles to compete with the demand for ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off ... but that’s not the reason it’s in shortage now. The surge in demand stems from people discovering its off ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Eli Lilly’s latest innovation, orforglipron, has emerged as a formidable contender in the weight-loss medication arena. The pill has demonstrated comparable results to Ozempic, a leading injectable ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...